Clinical Trial

A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study will be conducted to evaluate how a single oral dose of Gepotidacin is processed in the body over time along with safety monitoring in hospitalized pediatric participants who are receiving a standard of care treatment with antibacterials for a confirmed or suspected infection or for its prevention.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-19; most recent amendment 2026-04-22.
Trial Details
NCT Number NCT07371429
Lead Sponsor GlaxoSmithKline
Conditions Urinary Tract Infections
Enrollment 20 participants
Start Date 2026-04-29
Primary Completion 2027-08-23 (estimated)
Study Completion 2027-08-23 (estimated)
Updated on ClinicalTrials.gov 2026-04-23